CEBP Frontiers in Cancer Prevention Research - 2008 Cancer Health Disparities Conference 2009
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Cancer Research Clinical Cancer Research
Cancer Epidemiology Biomarkers & Prevention Molecular Cancer Therapeutics
Molecular Cancer Research Cancer Prevention Research
Cancer Prevention Journals Portal Cancer Reviews Online
Annual Meeting Education Book Meeting Abstracts Online

This Article
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Devesa, S. S.
Right arrow Articles by Blot, W. J.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Devesa, S. S.
Right arrow Articles by Blot, W. J.

Cancer Epidemiology Biomarkers & Prevention, Vol 1, Issue 1 29-34, Copyright © 1991 by American Association for Cancer Research


ARTICLES

Changing patterns of lung cancer incidence by histological type

SS Devesa, GL Shaw and WJ Blot
Division of Cancer Etiology, National Cancer Institute, Bethesda, Maryland 20892.

Using data from five registries covering 7% of the U.S. population, we investigated lung carcinoma incidence trends from 1969-86 by histological type, sex, race, age, calendar time period, and cohort year of birth. Among white men, squamous cell carcinoma was the most frequent histological type, but by the mid-1980s the age-adjusted rates were decreasing while rates of adenocarcinoma and small (oat) cell carcinoma continued to rise. Among white women, adenocarcinoma was the most frequent type, followed by small cell carcinoma, with rates of all histological types rising over the entire study period. Similar time trends were seen among blacks. Rates for squamous cell carcinoma among both sexes and adenocarcinoma among men, however, were considerably higher for blacks than whites, whereas no racial disparity was seen for small cell carcinomas. Rates for each histological type were higher among men than women, although male-female sex ratios diminished over time. Age-specific rates varied considerably by cohort year of birth; incidence of squamous cell carcinoma among men increased steadily among those born from the late 1800s to the first quarter of this century before declining among those born thereafter. Cohort peaks were also reached, although about 10 to 20 years later, for small cell carcinoma and adenocarcinoma, suggesting an eventual reduction in incidence in these histological types as well. For each type, the peak incidence occurred earlier for men than women. These differing incidence patterns add to the evidence that the mechanisms of lung carcinogenesis may vary by histological type.


This article has been cited by other articles:


Home page
Eur Respir JHome page
J. C. Ho, M. Chan-Yeung, S. P. Ho, J. C. Mak, M. S. Ip, G. C. Ooi, M. P. Wong, K. W. Tsang, and W. K. Lam
Disturbance of systemic antioxidant profile in nonsmall cell lung carcinoma
Eur. Respir. J., February 1, 2007; 29(2): 273 - 278.
[Abstract] [Full Text] [PDF]


Home page
Tobacco ControlHome page
N. Gray
The consequences of the unregulated cigarette.
Tob. Control, October 1, 2006; 15(5): 405 - 408.
[Abstract] [Full Text] [PDF]


Home page
CarcinogenesisHome page
J. E. Larsen, M. L. Colosimo, I. A. Yang, R. Bowman, P. V. Zimmerman, and K. M. Fong
CYP1A1 Ile462Val and MPO G-463A interact to increase risk of adenocarcinoma but not squamous cell carcinoma of the lung
Carcinogenesis, March 1, 2006; 27(3): 525 - 532.
[Abstract] [Full Text] [PDF]


Home page
Cancer Epidemiol. Biomarkers Prev.Home page
D. R. Brooks, J. H.M. Austin, R. T. Heelan, M. S. Ginsberg, V. Shin, S. H. Olson, J. E. Muscat, and S. D. Stellman
Influence of Type of Cigarette on Peripheral versus Central Lung Cancer
Cancer Epidemiol. Biomarkers Prev., March 1, 2005; 14(3): 576 - 581.
[Abstract] [Full Text] [PDF]


Home page
Clin. Cancer Res.Home page
M. Tokumo, S. Toyooka, K. Kiura, H. Shigematsu, K. Tomii, M. Aoe, K. Ichimura, T. Tsuda, M. Yano, K. Tsukuda, et al.
The Relationship between Epidermal Growth Factor Receptor Mutations and Clinicopathologic Features in Non-Small Cell Lung Cancers
Clin. Cancer Res., February 1, 2005; 11(3): 1167 - 1173.
[Abstract] [Full Text] [PDF]


Home page
CarcinogenesisHome page
W. Wu, S. Song, D. L. Ashley, and C. H. Watson
Assessment of tobacco-specific nitrosamines in the tobacco and mainstream smoke of Bidi cigarettes
Carcinogenesis, February 1, 2004; 25(2): 283 - 287.
[Abstract] [Full Text] [PDF]


Home page
JNCI J Natl Cancer InstHome page
M. Reck, J. von Pawel, H.-N. Macha, E. Kaukel, K.-M. Deppermann, R. Bonnet, K. Ulm, S. Hessler, and U. Gatzemeier
Randomized Phase III Trial of Paclitaxel, Etoposide, and Carboplatin Versus Carboplatin, Etoposide, and Vincristine in Patients With Small-Cell Lung Cancer
J Natl Cancer Inst, August 6, 2003; 95(15): 1118 - 1127.
[Abstract] [Full Text] [PDF]


Home page
Am J EpidemiolHome page
J. E. Olson, P. Yang, K. Schmitz, R. A. Vierkant, J. R. Cerhan, and T. A. Sellers
Differential Association of Body Mass Index and Fat Distribution with Three Major Histologic Types of Lung Cancer: Evidence from a Cohort of Older Women
Am. J. Epidemiol., October 1, 2002; 156(7): 606 - 615.
[Abstract] [Full Text] [PDF]


Home page
Cancer Res.Home page
G. Liu, D. P. Miller, W. Zhou, S. W. Thurston, R. Fan, L.-L. Xu, T. J. Lynch, J. C. Wain, L. Su, and D. C. Christiani
Differential Association of the Codon 72 p53 and GSTM1 Polymorphisms on Histological Subtype of Non-Small Cell Lung Carcinoma
Cancer Res., December 1, 2001; 61(24): 8718 - 8722.
[Abstract] [Full Text] [PDF]


Home page
JCOHome page
N. Ramnath, F. J. Hernandez, D.-F. Tan, J. A. Huberman, N. Natarajan, A. F. Beck, A. Hyland, I. T. Todorov, J. S.J. Brooks, and G. Bepler
MCM2 Is an Independent Predictor of Survival in Patients With Non-Small-Cell Lung Cancer
J. Clin. Oncol., November 15, 2001; 19(22): 4259 - 4266.
[Abstract] [Full Text]


Home page
Cancer Epidemiol. Biomarkers Prev.Home page
W. Zhou, S. W. Thurston, G. Liu, L. L. Xu, D. P. Miller, J. C. Wain, T. J. Lynch, L. Su, and D. C. Christiani
The Interaction between Microsomal Epoxide Hydrolase Polymorphisms and Cumulative Cigarette Smoking in Different Histological Subtypes of Lung Cancer
Cancer Epidemiol. Biomarkers Prev., May 1, 2001; 10(5): 461 - 466.
[Abstract] [Full Text]


Home page
Tobacco ControlHome page
N. Gray
Reflections on the saga of tar content: why did we measure the wrong thing?
Tob. Control, March 1, 2000; 9(1): 90 - 94.
[Full Text] [PDF]


Home page
CarcinogenesisHome page
G. B.J. Smith, A. Castonguay, P. J. Donnelly, K. R. Reid, D. Petsikas, and T. E. Massey
Biotransformation of the tobacco-specific carcinogen 4-(methylnitrosamino)-1-(3-pyridyl)-1-butanone (NNK) in freshly isolated human lung cells
Carcinogenesis, September 1, 1999; 20(9): 1809 - 1818.
[Abstract] [Full Text] [PDF]


Home page
Eur. J. Cardiothorac. Surg.Home page
M. de Perrot, M. Licker, J. Robert, and A. Spiliopoulos
Time trend in the surgical management of patients with lung carcinoma
Eur. J. Cardiothorac. Surg., April 1, 1999; 15(4): 433 - 437.
[Abstract] [Full Text] [PDF]


Home page
Ann. Thorac. Surg.Home page
W. C. Nugent, M. T. Edney, P. G. Hammerness, B. J. Dain, L. H. Maurer, and J. R. Rigas
Non-Small Cell Lung Cancer at the Extremes of Age: Impact on Diagnosis and Treatment
Ann. Thorac. Surg., January 1, 1997; 63(1): 193 - 197.
[Abstract] [Full Text]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Cancer Research Clinical Cancer Research
Cancer Epidemiology Biomarkers & Prevention Molecular Cancer Therapeutics
Molecular Cancer Research Cancer Prevention Research
Cancer Prevention Journals Portal Cancer Reviews Online
Annual Meeting Education Book Meeting Abstracts Online
Copyright © 1991 by the American Association for Cancer Research.